Point72 Asset Management, L.P.

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 1603466 STAMFORD, CT

Back to NAMS Full portfolio

Position in NAMS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,724,054

+$5,724,054 QoQ

Shares Held

168,901

Ownership

0.141%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#63

of 198 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Derivatives in NAMS

reported options exposure · as of Jun 30, 2026

CallValue

$620,187

CallShares

18,300

PutValue

$620,187

PutShares

18,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. NAMS ranks #74 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	4,473,478	$158,316,386
2	CYTK	Cytokinetics Inc	1,587,712	$135,257,185
3	BBIO	BridgeBio Pharma, Inc.	1,525,782	$113,640,243
4	AXSM	Axsome Therapeutics, Inc.	416,516	$101,950,621
5	LEGN	Legend Biotech Corp	3,076,124	$88,838,461
6	MDGL	Madrigal Pharmaceuticals, Inc.	137,029	$73,577,721
7	CELC	Celcuity Inc.	650,916	$68,098,831
8	ACAD	Acadia Pharmaceuticals Inc	2,433,168	$61,559,150

All Filings in NAMS

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$620,187	18,300	+0.5%	Put	Defined	2026-08-14
2026-06-30	$620,187	18,300	+0.5%	Call	Defined	2026-08-14
2026-06-30	$5,724,054	168,901	—	Shares	Defined	2026-08-14
2026-03-31	$582,582	18,200	—	Put	Defined	2026-05-15
2026-03-31	$582,582	18,200	—	Call	Defined	2026-05-15
No filing history on record for this holder in this stock.